Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Julia Frede, Ph.D.

Concepts (88)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Receptors, CXCR4120217280.550 Why?
Multiple Myeloma6202451300.510 Why?
Cell Transformation, Neoplastic3202428280.450 Why?
Neoplastic Stem Cells3202113470.450 Why?
Autocrine Communication120131690.420 Why?
Aquaporins120131740.410 Why?
Esophageal Neoplasms3201616480.380 Why?
Neoplasms, Glandular and Epithelial120144870.350 Why?
Epithelium1201416050.340 Why?
Drug Resistance, Neoplasm4202152530.340 Why?
Cell Division1201644630.320 Why?
Ion Channels1201310430.310 Why?
Transcription, Genetic1202175930.290 Why?
Cell Lineage5202425330.280 Why?
Immunotherapy1202146420.260 Why?
Stem Cells2201435230.230 Why?
Cell Differentiation22016114810.190 Why?
Cell Proliferation22016104460.190 Why?
Antineoplastic Agents22021136300.180 Why?
Galectins120212820.150 Why?
Immune Evasion120213620.150 Why?
Gene Expression Regulation, Leukemic120216460.150 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120213810.140 Why?
Mutation52021299320.130 Why?
Ovarian Neoplasms1201348780.130 Why?
Lymphoma, B-Cell120229350.130 Why?
Gene Expression Regulation, Neoplastic4202485150.130 Why?
Tumor Microenvironment2202438440.120 Why?
B-Lymphocytes2202447420.120 Why?
Clone Cells2201416600.120 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma1202215470.110 Why?
Single-Cell Analysis2202123800.110 Why?
Gene Regulatory Networks1202117410.100 Why?
Drug Resistance, Multiple120132540.100 Why?
Proto-Oncogene Proteins1202444900.100 Why?
Signal Transduction22024233760.090 Why?
Molecular Targeted Therapy1202128030.090 Why?
Cell Line, Tumor22023169390.080 Why?
Esophagus1201410230.080 Why?
Mice, Transgenic2201695300.070 Why?
Melanoma1202156970.050 Why?
Animals620241679630.050 Why?
Interleukin-15120231830.050 Why?
Epigenesis, Genetic1201437580.050 Why?
Humans1420247606210.040 Why?
Germinal Center120223790.040 Why?
Antigens, CD19120224240.040 Why?
Optometry11978290.040 Why?
Societies119781080.040 Why?
Ligands1202432760.040 Why?
Aged, 80 and over12021589950.030 Why?
Treatment Failure1202226480.030 Why?
Paris12014500.030 Why?
Killer Cells, Natural1202322030.030 Why?
Tumor Cells, Cultured1202161310.030 Why?
Receptors, Antigen, T-Cell1202225360.030 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202416280.030 Why?
Xenograft Model Antitumor Assays1202135840.030 Why?
Immunotherapy, Adoptive1202214540.030 Why?
Prognosis22024296580.020 Why?
Aged220211691520.020 Why?
Proto-Oncogene Proteins B-raf1202120530.020 Why?
Female320213912700.020 Why?
Middle Aged220212203520.020 Why?
Receptors, Notch120147430.020 Why?
Cytokines1202373430.020 Why?
Follow-Up Studies22021392610.020 Why?
Disease Progression12024135020.020 Why?
Sequence Analysis, DNA1201847130.020 Why?
Male220213597440.020 Why?
Disease Models, Animal12024181370.020 Why?
Protein Kinase Inhibitors1202156430.020 Why?
T-Lymphocytes12022101810.020 Why?
Neoplasm Recurrence, Local1202192760.010 Why?
Mice22024812080.010 Why?
Case-Control Studies12018220530.010 Why?
Nuclear Proteins1201457910.010 Why?
Infant12021360600.010 Why?
Child, Preschool12021420630.010 Why?
Persuasive Communication11978580.010 Why?
Young Adult12021587410.010 Why?
Transcription Factors12014121030.010 Why?
Child12021798060.010 Why?
Adolescent12021878100.010 Why?
Time Factors12014401650.010 Why?
Motivation1197819930.000 Why?
Adult120212199940.000 Why?
United States11978724610.000 Why?
Frede's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (88)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.